My ePortfolio Register   

Combining immune-based therapies with TKIs in melanomas

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 227
Rating:

Prof Caroline Robert - Institute Gustave Roussy, Paris, France

Prof Robert speaks with ecancer at WIN 2017 about tackling class-associated toxicity and drug resistance with combination therapies based on tyrosine kinase inhibition.

Intralesional oncolytic therapies for melanoma were also discussed by Dr Sanjiv Agarwala at EADO 2017, here. 

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence